Modeling amantadine treatment of influenza A virus in vitro

From MaRDI portal
Publication:1797505

DOI10.1016/J.JTBI.2008.05.031zbMath1400.92314OpenAlexW2019858673WikidataQ37145829 ScholiaQ37145829MaRDI QIDQ1797505

Ruy M. Ribeiro, Jack T. Nguyen, Catherine A. A. Beauchemin, George L. Drusano, James J. McSharry, Gregory T. Went, Alan S. Perelson

Publication date: 22 October 2018

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc2663526




Related Items (24)

Assessing uncertainty in A2 respiratory syncytial virus viral dynamicsA within-host mathematical model of H9N2 avian influenza infection and type-I interferon response pathways in chickensPredicting pathogen-specific CD8 T cell immune responses from a modeling approachExistence of a conserved quantity and stability of \textit{in vitro} virus infection dynamics models with absorption effectModeling inoculum dose dependent patterns of acute virus infectionsTowards multiscale modeling of influenza infectionMathematical model of immune response to hepatitis BData-driven models for replication kinetics of \textit{Orthohantavirus} infectionsA conservation law for virus infection kinetics \textit{in vitro}On the extinction probability in models of within-host infection: the role of latency and immunityTime-delayed model of autoimmune dynamicsTHE DYNAMICS AND THERAPEUTIC STRATEGIES OF A SEIS EPIDEMIC MODELStationary distribution and extinction of a stochastic HLIV model with viral production and Ornstein-Uhlenbeck processMultiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: parameter estimates, identifiability, sensitivity and the eclipse phase profileSimplified within-host and dose-response models of SARS-CoV-2Modeling of fusion inhibitor treatment of RSV in African green monkeysMathematical model of the primary CD8 T cell immune response: stability analysis of a nonlinear age-structured systemProbability of a major infection in a stochastic within-host model with multiple stagesMODELING STRATEGIES FOR CONTROLLING H1N1 OUTBREAKS IN CHINAThe effect of delay in viral production in within-host models during early infectionDetermining drug efficacy parameters for mathematical models of influenzaNeuraminidase inhibitors for treatment of human and avian strain influenza: a comparative modeling studyQuantifying relative within-host replication fitness in influenza virus competition experimentsMathematical modelling of acute virus influenza A infections


Uses Software



Cites Work




This page was built for publication: Modeling amantadine treatment of influenza A virus in vitro